Advertisement
Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg
&format=webp)
The sign of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19, 2015. REUTERS/Christinne Muschi
(Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.
Advertisement
A sale could value Amoun at $700 million to $800 million, Bloomberg reported. (http://bloom.bg/1EXe5PQ)
Advertisement
Valeant was not immediately available for comment.
Should Amoun fail to find a buyer, it may consider an initial public offering in London, the report said.
Amoun could not be immediately reached for comment.
Advertisement
Subscribe
Sportal WhatsApp
Latest Videos
Advertisement
Videos
-
World 20.08.2018Celebrating the African diplomat legend
Advertisement
Advertisement
More from Pulse Nigeria
&format=webp)
&format=webp)
&format=webp)
&format=webp)
&format=webp)
&format=webp)
Advertisement